
January to March 2023
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| AFLIBERCEPT | $127,401,581 | 121,724 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $122,322,742 | 5,726 |
| PEMBROLIZUMAB | $115,720,489 | 13,581 |
| NIVOLUMAB | $108,116,001 | 14,857 |
| USTEKINUMAB | $90,301,308 | 12,329 |
| MOLNUPIRAVIR | $88,265,488 | 76,526 |
| ADALIMUMAB | $77,753,155 | 85,987 |
| APIXABAN | $74,590,959 | 914,872 |
| DENOSUMAB | $67,570,555 | 269,121 |
| NIRMATRELVIR (&) RITONAVIR | $66,248,240 | 54,920 |
| DUPILUMAB | $66,164,922 | 38,578 |
| OCRELIZUMAB | $56,993,466 | 3,294 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $20,485,780 | 4,010,611 |
| ATORVASTATIN | $16,553,402 | 2,928,300 |
| PANTOPRAZOLE | $13,818,015 | 2,457,282 |
| ESOMEPRAZOLE | $13,039,656 | 1,966,979 |
| PERINDOPRIL | $8,896,949 | 1,725,102 |
| ESCITALOPRAM | $5,080,291 | 1,501,265 |
| SERTRALINE | $5,213,310 | 1,391,243 |
| METFORMIN | $7,577,860 | 1,356,885 |
| CEFALEXIN | $5,092,455 | 1,294,893 |
| AMLODIPINE | $6,028,418 | 1,160,755 |
| TELMISARTAN | $5,296,208 | 1,106,508 |
| CANDESARTAN | $5,140,842 | 1,012,792 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $3,976,998,814 |
| Patients | $915,941,937 |